Skip to Main Content

Paper Details

Romidepsin enhances the efficacy of cytarabine <i>in vivo</i>, revealing histone deacetylase inhibition as a promising therapeutic strategy for <i>KMT2A</i>-rearranged infant acute lymphoblastic leukemia.
Haematologica
10
2019
Author NameAffiliation
Richard B LockChildren's Cancer Institute, Lowy Cancer Research Centre
  • 1 - 1

Datasets

Release 1.2